Global Continuous Glucose Monitoring Devices Market Size, Share, And Forecast, 2026-2033 Connected CGM And Real-Time Care Drive 15.10% CAGR To $49.87 Billion


Date:

(MENAFN- GlobeNewsWire - Nasdaq) Rising diabetes prevalence, real-time personalized care, minimally invasive sensors and automated insulin delivery partnerships drive CGM adoption.

Dublin, Nov. 20, 2026 (GLOBE NEWSWIRE) -- "Continuous Glucose Monitoring Devices Market Size, Share & Trends Analysis Report by Product, Connectivity, Indication, Distribution Channel, Region, and Growth Forecasts, 2026-2033" has been added to ResearchAndMarkets.com's offering.

The global continuous glucose monitoring devices market was valued at USD 13.38 billion in 2025 and is projected to reach USD 49.87 billion by 2033, expanding at a compound annual growth rate of 15.10% from 2026 to 2033. Market growth is being driven by rising diabetes prevalence, technological innovation, increasing clinical demand, and the transition toward personalized, real-time diabetes care.

The growing global burden of diabetes continues to accelerate demand for continuous glucose monitoring devices. According to the International Diabetes Federation, approximately 589 million adults worldwide were living with diabetes as of 2024. This expanding patient population is increasing the need for accurate and timely glucose data that can support glycemic control, reduce the risk of hypoglycemic events, and improve diabetes management outcomes.

Continuous glucose monitoring systems use sensor-based technology and wireless connectivity to track glucose levels at regular intervals. Readings can be transmitted to compatible devices and diabetes management software, allowing patients and healthcare providers to monitor glucose trends and make informed treatment decisions. Adoption is also supported by the need to manage diabetes complications associated with obesity, smoking, physical inactivity, high blood pressure, and high cholesterol.

Product innovation and integration with automated insulin delivery systems are strengthening the market outlook. In January 2024, Medtronic received CE Mark approval in Europe for its MiniMed 780G system with Simplera Sync, a next-generation, minimally invasive CGM sensor designed to integrate with the company's automated insulin delivery pump.

Strategic collaborations are also advancing connected diabetes care. In August 2024, Abbott and Medtronic announced a global partnership to integrate Abbott's FreeStyle Libre CGM technology with Medtronic's automated insulin delivery systems. The collaboration is expected to simplify diabetes management, improve access to connected treatment options, and reduce the burden of frequent self-monitoring.

Market Segmentation

The report provides revenue forecasts and analysis of industry trends and growth opportunities across product, connectivity, indication, distribution channel, and regional segments from 2021 to 2033.

Product Outlook (Revenue, USD Million, 2021-2033)

  • Sensors
  • Device/Readers
  • Applicators
  • Transmitters

Connectivity Outlook (Revenue, USD Million, 2021-2033)

  • Bluetooth
  • 4G/Cellular
  • Near Field Communication (NFC)

Indication Outlook (Revenue, USD Million, 2021-2033)

  • Type 1 Diabetes
  • Type 2 Diabetes

Distribution Channel Outlook (Revenue, USD Million, 2021-2033)

  • Pharmacies
  • E-commerce
  • Other

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America: U.S., Canada, and Mexico
  • Europe: UK, Germany, France, Italy, Spain, Denmark, Sweden, and Norway
  • Asia Pacific: Japan, China, India, Australia, South Korea, and Thailand
  • Latin America: Brazil and Argentina
  • Middle East & Africa: South Africa, Saudi Arabia, UAE, and Kuwait

Key Benefits of the Report

  • Comprehensive analysis of the continuous glucose monitoring devices market across major segments and regions
  • Revenue estimates and forecasts supporting market assessment and strategic planning
  • Evaluation of emerging technologies, product innovation, and future market trends
  • Competitive landscape and market share analysis of key industry participants
  • Identification of growth opportunities and potential revenue streams
  • Actionable market intelligence to support investment, expansion, and product development decisions

The report offers a detailed assessment of the factors shaping the continuous glucose monitoring devices market, including connected care technologies, automated insulin delivery integration, changing distribution models, and increasing demand for personalized diabetes management. These insights can help healthcare companies, investors, manufacturers, and other stakeholders evaluate market opportunities and develop informed growth strategies through 2033.

Key Attributes:

Report Attribute Details
No. of Pages 140
Forecast Period 2025 - 2033
Estimated Market Value (USD) in 2025 $13.38 Billion
Forecasted Market Value (USD) by 2033 $41.41 Billion
Compound Annual Growth Rate 15.1%
Regions Covered Global


Key Topics Covered:
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Connectivity
1.2.3. Indication
1.2.4. Distribution Channel
1.2.5. Regional scope
1.2.6. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. Internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Connectivity outlook
2.2.3. Indication outlook
2.2.4. Distribution channel outlook
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. Continuous Glucose Monitoring (CGM) Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Continuous Glucose Monitoring (CGM) Devices Market Analysis Tools
3.3.1. Industry Analysis - Porter's
3.3.2. PESTEL Analysis
Chapter 4. Continuous Glucose Monitoring (CGM) Devices Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Continuous Glucose Monitoring (CGM) Devices Market: Product Movement Analysis
4.3. Continuous Glucose Monitoring (CGM) Devices Market by Product Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
4.5. Sensors
4.5.1. Sensors Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.6. Device/Readers
4.6.1. Device/Readers Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.7. Applicators
4.7.1. Applicators Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.8. Transmitters
4.8.1. Transmitters Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 5. Continuous Glucose Monitoring (CGM) Devices Market: Connectivity Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Continuous Glucose Monitoring (CGM) Devices Market: Connectivity Movement Analysis
5.3. Continuous Glucose Monitoring (CGM) Devices Market by Connectivity Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
5.5. Bluetooth
5.5.1. Bluetooth Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.6. 4G/Cellular
5.6.1. 4G/Cellular Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.7. Near Field Communication (NFC)
5.7.1. Near Field Communication Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 6. Continuous Glucose Monitoring (CGM) Devices Market: Indication Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Continuous Glucose Monitoring (CGM) Devices Market: Indication Movement Analysis
6.3. Continuous Glucose Monitoring (CGM) Devices Market by Indication Outlook (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
6.5. Type 1 Diabetes
6.5.1. Type 1 Diabetes Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.6. Type 2 Diabetes
6.6.1. Type 2 Diabetes Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 7. Continuous Glucose Monitoring (CGM) Devices Market: Distribution Channel Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Continuous Glucose Monitoring (CGM) Devices Market: Distribution Channel Movement Analysis
7.3. Continuous Glucose Monitoring (CGM) Devices Market by Distribution Channel Outlook (USD Million)
7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
7.5. Pharmacies
7.5.1. Pharmacies Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
7.6. E-commerce
7.6.1. E-commerce Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
7.7. Others
7.7.1. Others Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 8. Continuous Glucose Monitoring (CGM) Devices Market: Regional Estimates & Trend Analysis
8.1. Regional Dashboard
8.2. Regional Continuous Glucose Monitoring (CGM) Devices Market Movement Analysis
8.3. Continuous Glucose Monitoring (CGM) Devices Market: Regional Estimates & Trend Analysis by Product & End-use
8.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
8.5. North America
8.5.1. North America Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021-2033 (USD Million)
8.5.2. U.S.
8.5.3. Canada
8.5.4. Mexico
8.6. Europe
8.6.1. Europe Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021-2033 (USD Million)
8.6.2. UK
8.6.3. Germany
8.6.4. France
8.6.5. Italy
8.6.6. Spain
8.6.7. Denmark
8.6.8. Sweden
8.6.9. Norway
8.7. Asia-Pacific
8.7.1. Asia-Pacific Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021-2033 (USD Million)
8.7.2. Japan
8.7.3. China
8.7.4. India
8.7.5. South Korea
8.7.6. Australia
8.7.7. Thailand
8.8. Latin America
8.8.1. Latin America Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021-2033 (USD Million)
8.8.2. Brazil
8.8.3. Argentina
8.9. Middle East & Africa
8.9.1. Middle East & Africa Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021-2033 (USD Million)
8.9.2. South Africa
8.9.3. Saudi Arabia
8.9.4. UAE
8.9.5. Kuwait
Chapter 9. Competitive Landscape
9.1. Market Participant Categorization
9.2. Key Company Profiles
9.2.1. DexCom, Inc.
9.2.2. Abbott Laboratories
9.2.3. Medtronic plc
9.2.4. Sensonics Holdings, Inc.
9.2.5. Sinocare, Inc
9.2.6. i-SENS, Inc.
9.2.7. Zhejiang POCTech Co., Ltd.
9.2.8. GlucoRx Limited
9.2.9. F. Hoffmann-La Roche Ltd.
9.2.10. Nemaura
9.2.11. Bionime
List of Tables [122]
List of Figures [61]
Companies Featured

  • DexCom, Inc.
  • Abbott Laboratories
  • Medtronic plc
  • Sensonics, Inc.
  • Sinocare, Inc. (iCan CGM)
  • i-SENS, Inc.
  • Zhejiang POCTech Co., Ltd.
  • GlucoRx Limited (AiDEX, Vixxa)
  • F. Hoffmann-La Roche Ltd.
  • Nemaura
  • Bionime (RIGHTEST iFree CGM)

For more information about this report visit

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN20112026004107003653ID1111997044


GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.



More Story

Search